Research chemical sequence
Vesugen
Vesugen is listed as a research-use-only chemical sequence. Research use only. Not for human or veterinary use. Public catalog information is limited to chemical identity, analytical documentation, and external reference records.
Research-use boundary: Research use only. Not for human or veterinary use. Public catalog information is limited to chemical identity, analytical documentation, and external reference records.
Public identity
- Publication state
- unpublished
- Sequence
- Lys-Glu-Asp
- IUPAC name
- L-Lysyl-L-glutamyl-L-aspartic acid
- Molecular formula
- C15H26N4O8
Available variants
| Size | SKU | Price (USD) | Availability | Representative purity |
|---|---|---|---|---|
| 20mg | DFP-002 | $0.00 | Out of stock | 99.3% |
Analytical boundary
Representative catalog purity: 99.3%
No active-batch certificate of analysis is currently published.
Purity figures shown here are representative catalog specifications, not lot-specific measurements.
Evidence inventory
- Record state
- reviewed records
- Public records
- 38
- Reviewed summaries
- 2
- Verified citations
- 0
- Human study: 4
- In vivo: 4
- In vitro: 30
- Special category: 0
- Unclassified: 0
These counts describe linked records and review status. They do not establish efficacy, safety, or fitness for any use.
Technical record
- CAS number
- 110431-82-4
- Molecular weight
- 400.4 Da
- Sequence class
- peptide
- Molecular formula
- C15H26N4O8
- Appearance
- White to off-white lyophilized powder.
- Solubility
- Hydrophilic. Readily soluble in water (e.g., ultrapure water, PBS) at concentrations up to 10 mg/mL. For optimal stability, reconstitute in sterile, deionized water or PBS (pH 7.0-7.4). Avoid strong acidic or basic conditions for prolonged storage.
- Mechanism record
- Vesugen (Lys-Glu-Asp) is a Khavinson 3-residue chemical sequence bioregulator with tissue-specific affinity for vascular endothelium. It binds AT-rich DNA motifs in promoter regions of vascular genes, normalizing endothelial protein synthesis, improving vascular tone regulation, and modulating nitric oxide synthase expression. Studied for age-related vascular function restoration in preclinical models.
- Half-life record
- ~20–30 minutes (SubQ, plasma)
Recorded receptors
- Vascular endothelial receptors
- smooth muscle cell targets
External literature records
- External literature record
Limitations and research boundary
Research use only. Not for human or veterinary use. Public catalog information is limited to chemical identity, analytical documentation, and external reference records.
External records are attributed references. Their presence does not convert a source-reported observation into a product claim.